Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -48.49% is 27% below its 5-year average of -38.29%, near the low end of its 5-year range (-53.39%–-24.78%).
3.37% above its 12-month average of -50.18%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -11.46%.
RETURN ON ASSETS (ROA)
-48.49%
RETURN ON ASSETS (ROA) AVG TTM
-50.18%
RETURN ON ASSETS (ROA) AVG 3Y
-39.97%
RETURN ON ASSETS (ROA) AVG 5Y
-38.29%
RETURN ON ASSETS (ROA) AVG 10Y
-47.17%
RETURN ON ASSETS (ROA) AVG 15Y
-48.16%
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+3.37%
CURRENT VS 3Y AVG
-21.32%
CURRENT VS 5Y AVG
-26.66%
CURRENT VS 10Y AVG
-2.80%
CURRENT VS 15Y AVG
-0.69%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.05%
median of 560 covered companies
CURRENT VS SECTOR MEDIAN
-72.90%
vs the sector median at left
Aldeyra The
Market Cap
$59.07M
Return on Assets (ROA)
-48.49%
TTM Avg
-50.18%
3Y Avg
-39.97%
5Y Avg
-38.29%
Market Cap
$58.97M
Return on Assets (ROA)
-128.88%
TTM Avg
-89.84%
3Y Avg
-89.26%
5Y Avg
-80.42%
Market Cap
$58.66M
Return on Assets (ROA)
-37.05%
TTM Avg
-34.36%
3Y Avg
-41.63%
5Y Avg
-37.74%
Market Cap
$59.51M
Return on Assets (ROA)
-118.15%
TTM Avg
-138.13%
3Y Avg
-224.99%
5Y Avg
-221.92%
Market Cap
$60.39M
Return on Assets (ROA)
-66.80%
TTM Avg
-56.95%
3Y Avg
-50.95%
5Y Avg
-40.99%
Market Cap
$57.33M
Return on Assets (ROA)
-54.01%
TTM Avg
-81.00%
3Y Avg
-93.15%
5Y Avg
-65.68%
Market Cap
$56.10M
Return on Assets (ROA)
-98.94%
TTM Avg
-57.19%
3Y Avg
-57.75%
5Y Avg
-128.29%
Market Cap
$62.78M
Return on Assets (ROA)
-5.05%
TTM Avg
-7.03%
3Y Avg
-4.31%
5Y Avg
-4.67%
Market Cap
$54.90M
Return on Assets (ROA)
-162.93%
TTM Avg
-287.06%
3Y Avg
-300.16%
5Y Avg
-220.25%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aldeyra The (ALDX) | $59.07M | -48.49% | -50.18% | -39.97% | -38.29% |
| Fractyl Health, Inc. (GUTS)vs › | $58.97M | -128.88% | -89.84% | -89.26% | -80.42% |
| Boundless Bio, Inc. (BOLD)vs › | $58.66M | -37.05% | -34.36% | -41.63% | -37.74% |
| MiNK Therapeutics, Inc. (INKT)vs › | $59.51M | -118.15% | -138.13% | -224.99% | -221.92% |
| Adicet Bio, Inc. (ACET)vs › | $60.39M | -66.80% | -56.95% | -50.95% | -40.99% |
| Spectral AI, Inc. (MDAI)vs › | $57.33M | -54.01% | -81.00% | -93.15% | -65.68% |
| Connect Biopharma Holdings Limited (CNTB)vs › | $56.10M | -98.94% | -57.19% | -57.75% | -128.29% |
| InterCure Ltd. (INCR)vs › | $62.78M | -5.05% | -7.03% | -4.31% | -4.67% |
| Apollomics, Inc. (APLM)vs › | $54.90M | -162.93% | -287.06% | -300.16% | -220.25% |
| Kalaris Therapeutics Inc (KLRS)vs › | $63.95M | -44.47% | -42.63% | -230.85% | -167.04% |
ROA
-48.5%
ROE
-60.9%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -46.97% |
| 2024-12-31 | -53.39% |
| 2023-12-31 | -25.31% |
| 2022-12-31 | -34.21% |
| 2021-12-31 | -24.78% |
| 2020-12-31 | -45.05% |
| 2019-12-31 | -80.55% |
| 2018-12-31 | -40.90% |
| 2017-12-31 | -50.57% |
| 2016-12-31 | -74.24% |
| 2015-12-31 | -42.87% |
| 2014-12-31 | -59.03% |
| 2013-12-31 | 348.90% |
| 2012-12-31 | -1167.16% |
| 2011-12-31 | -918.49% |
